Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.

Nagao-Kitamoto H, Shreiner AB, Gillilland MG 3rd, Kitamoto S, Ishii C, Hirayama A, Kuffa P, El-Zaatari M, Grasberger H, Seekatz AM, Higgins PD, Young VB, Fukuda S, Kao JY, Kamada N.

Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481.

2.

Inflammatory Th1 and Th17 in the Intestine Are Each Driven by Functionally Specialized Dendritic Cells with Distinct Requirements for MyD88.

Liang J, Huang HI, Benzatti FP, Karlsson AB, Zhang JJ, Youssef N, Ma A, Hale LP, Hammer GE.

Cell Rep. 2016 Oct 25;17(5):1330-1343. doi: 10.1016/j.celrep.2016.09.091.

3.

Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome.

Chudnovskiy A, Mortha A, Kana V, Kennard A, Ramirez JD, Rahman A, Remark R, Mogno I, Ng R, Gnjatic S, Amir ED, Solovyov A, Greenbaum B, Clemente J, Faith J, Belkaid Y, Grigg ME, Merad M.

Cell. 2016 Oct 6;167(2):444-456.e14. doi: 10.1016/j.cell.2016.08.076.

PMID:
27716507
4.

Gut microbiota-host interactions and juvenile idiopathic arthritis.

Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML.

Pediatr Rheumatol Online J. 2016 Jul 22;14(1):44. doi: 10.1186/s12969-016-0104-6. Review.

5.

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Wu W, Chen F, Liu Z, Cong Y.

Inflamm Bowel Dis. 2016 Jun;22(6):1473-82. doi: 10.1097/MIB.0000000000000775.

PMID:
27057688
6.

TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells.

Liu H, Chen F, Wu W, Cao AT, Xue X, Yao S, Evans-Marin HL, Li YQ, Cong Y.

Sci Rep. 2016 Feb 24;6:22040. doi: 10.1038/srep22040.

7.

Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.

Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J, Baldassano RN, Sonnenberg GF.

Nat Med. 2016 Mar;22(3):319-23. doi: 10.1038/nm.4046.

8.

Luminal Conversion and Immunoregulation by Probiotics.

Ganesh BP, Versalovic J.

Front Pharmacol. 2015 Nov 12;6:269. doi: 10.3389/fphar.2015.00269. Review.

9.

T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.

Larmonier CB, Shehab KW, Ghishan FK, Kiela PR.

Biomed Res Int. 2015;2015:504638. doi: 10.1155/2015/504638. Review.

10.

The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community.

Wymore Brand M, Wannemuehler MJ, Phillips GJ, Proctor A, Overstreet AM, Jergens AE, Orcutt RP, Fox JG.

ILAR J. 2015;56(2):169-78. doi: 10.1093/ilar/ilv012. Review.

11.

Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development.

Evans-Marin HL, Cao AT, Yao S, Chen F, He C, Liu H, Wu W, Gonzalez MG, Dann SM, Cong Y.

PLoS One. 2015 Jul 31;10(7):e0134100. doi: 10.1371/journal.pone.0134100.

12.

The Importance of IL-6 in the Development of LAT-Mediated Autoimmunity.

O'Brien SA, Zhu M, Zhang W.

J Immunol. 2015 Jul 15;195(2):695-705. doi: 10.4049/jimmunol.1403187.

13.

mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages.

Bao W, Wang Y, Fu Y, Jia X, Li J, Vangan N, Bao L, Hao H, Wang Z.

PLoS One. 2015 May 5;10(5):e0125910. doi: 10.1371/journal.pone.0125910.

14.
15.

CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.

Wendt E, Keshav S.

Clin Exp Gastroenterol. 2015 Apr 7;8:119-30. doi: 10.2147/CEG.S48305. Review.

16.

Harnessing regulatory T cells for the treatment of inflammatory bowel disease.

Geem D, Harusato A, Flannigan K, Denning TL.

Inflamm Bowel Dis. 2015 Jun;21(6):1409-18. doi: 10.1097/MIB.0000000000000343. Review.

17.

The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.

Tang W, Wang H, Claudio E, Tassi I, Ha HL, Saret S, Siebenlist U.

Immunity. 2014 Oct 16;41(4):555-66. doi: 10.1016/j.immuni.2014.09.017.

18.

Microbiota activation and regulation of innate and adaptive immunity.

Alexander KL, Targan SR, Elson CO 3rd.

Immunol Rev. 2014 Jul;260(1):206-20. doi: 10.1111/imr.12180. Review.

19.

Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Rothlin CV, Leighton JA, Ghosh S.

Inflamm Bowel Dis. 2014 Aug;20(8):1472-80. doi: 10.1097/MIB.0000000000000050. Review.

20.

Regulation of the immune system by the resident intestinal bacteria.

Kamada N, Núñez G.

Gastroenterology. 2014 May;146(6):1477-88. doi: 10.1053/j.gastro.2014.01.060. Review.

Items per page

Supplemental Content

Support Center